Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHeadlam Regulatory News (HEAD)

Share Price Information for Headlam (HEAD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 179.00
Bid: 178.00
Ask: 181.00
Change: 1.00 (0.56%)
Spread: 3.00 (1.685%)
Open: 180.00
High: 180.00
Low: 179.00
Prev. Close: 178.00
HEAD Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Grant of awards under Deferred Bonus Plan & PSP

18 Mar 2024 16:57

RNS Number : 3014H
Headlam Group PLC
18 March 2024
 

18 March 2024

 

Headlam Group plc

(the 'Company')

Grant of awards under Deferred Bonus Plan & Performance Share Plan

 

Performance Share Plan awards

On 18 March 2024, the Company granted awards in the form of nil-cost options over a total of 935,334 ordinary shares of 5 pence each in the Company under the Company's Performance Share Plan, (the 'PSP'), including 660,635 to the following Executive Directors:

 

 

Executive Director / PDMR

 

 

 

Role

 

Number of ordinary shares over which PSP awards granted

 

Chris Payne

 

 

Chief Executive

395,402

Adam Phillips

 

Chief Financial Officer

265,233

 

As detailed in the 2023 Annual Report and Accounts published on 18 March, vesting of the PSP awards is dependent on continued employment and the achievement of performance conditions against the following measures:

- compound growth in Earnings Per Share (70%);

- relative Total Shareholder Return performance measured against the constituents of the FTSE SmallCap Index (excluding investment trusts) (20%); and

- reduction in greenhouse gas emissions (10%).

 

The performance conditions will be measured over a three-year performance period. 

In addition, the awards are further subject to an underpin performance condition that the extent of vesting reflects the overall financial performance of the Company over the three-year performance period. When making this determination the Company's Remuneration Committee will have full discretion to ensure that the final outcome is warranted based on the performance of the Company in light of all relevant factors to ensure there have been no windfalls gains.

PSP awards granted to Executive Directors are additionally subject to a two-year holding period following the date of vesting during which a dividend equivalent will accrue in the form of additional shares to the extent the awards vest, as calculated on a re-investment basis.

The number of ordinary shares over which the awards were granted was calculated on a share price of 183.80 pence per ordinary share, being the average mid-market closing share price for the five business days prior to the grant date, as derived from the London Stock Exchange daily official list. The awards are subject to the malus and clawback provisions of the PSP.

Deferred Bonus Plan ('DBP') awards

As detailed in the Directors' Remuneration Report on page 116 of the 2023 Annual Report and Accounts, rather than defer one-third of the bonus outcome into an award over shares, the Remuneration Committee has decided to defer 100% of the Executive Director's 2023 bonus outcome into an award under the DBP.

On 18 March 2024, the Company granted nil-cost options under the DBP to the following Executive Directors:

 

Executive Director / PDMR

 

 

 

Role

 

Amount of Bonus Deferred (£)

 

Number of ordinary shares over which DBP awards granted

 

Chris Payne

 

 

Chief Executive

 

118,750

 

64,608

Adam Phillips

 

Chief Financial Officer

54,375*

 

29,583

 

* Pro-rated as Adam Phillips to reflect that he joined the Company on 20 March 2023.

The 2024 DBP awards will not vest until the second anniversary of the grant date, and are subject to a dividend equivalent in the form of shares, calculated on a re-investment basis. The number of ordinary shares over which the awards were granted was calculated based on a share price of 183.80 pence per ordinary share, being the average mid-market closing share price for the five business days prior to the grant date, as derived from the London Stock Exchange daily official list.

 

Headlam Group plc

Tel: 01675 433 000

Chris Payne, Chief Executive

Email: headlamgroup@headlam.com

Adam Phillips, Chief Financial Officer

 

Alison Hughes, General Counsel & Company Secretary

Panmure Gordon (UK) Limited (Corporate Broker)

Tel: 020 7886 2500

Tom Scrivens / Atholl Tweedie

 

Peel Hunt LLP (Corporate Broker)

 

 

Tel: 020 7418 8900

George Sellar / Finn Nugent

 

 

 

 

 

 

 

 

 

 Notification and public disclosure of transactions by persons discharging managerial

 responsibilities / persons closely associated with them.

 

1.

Details of PDMR / person closely associated with them ("PCA")

a)

Name

Chris Payne

2.

Reason for the notification

a)

Position / status

Chief Executive

b)

Initial notification / amendment

Initial notification

3.

Details of the issuer

a)

Name

Headlam Group plc

b)

LEI

213800I4AZZUJEYX9O90

4.

Details of the transaction(s): section to be repeated for (i) each type of

instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary shares of 5 pence each. 

b)

Identification code

ISIN: GB0004170089

c)

Nature of the transaction

Grant of nil-cost options over Ordinary Shares under the Company's Deferred Bonus Plan

d)

Price(s) and

volume(s)

Price(s)

Volume(s)

Nil

64,608

e)

Aggregated information

- Volume

- Price

N/A

f)

Date of the transaction

18 March 2024

g)

Place of the transaction

Outside a trading venue

 

 

1.

Details of PDMR / person closely associated with them ("PCA")

a)

Name

Adam Phillips

2.

Reason for the notification

a)

Position / status

Chief Financial Officer

b)

Initial notification / amendment

Initial notification

3.

Details of the issuer

a)

Name

Headlam Group plc

b)

LEI

213800I4AZZUJEYX9O90

4.

Details of the transaction(s): section to be repeated for (i) each type of

instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary shares of 5 pence each. 

b)

Identification code

ISIN: GB0004170089

c)

Nature of the transaction

Grant of nil-cost options over Ordinary Shares under the Company's Deferred Bonus Plan

d)

Price(s) and

volume(s)

Price(s)

Volume(s)

Nil

29,583

e)

Aggregated information

- Volume

- Price

N/A

f)

Date of the transaction

18 March 2024

g)

Place of the transaction

Outside a trading venue

 

 

1.

Details of PDMR / person closely associated with them ("PCA")

a)

Name

Chris Payne

2.

Reason for the notification

a)

Position / status

Chief Executive

b)

Initial notification / amendment

Initial notification

3.

Details of the issuer

a)

Name

Headlam Group plc

b)

LEI

213800I4AZZUJEYX9O90

4.

Details of the transaction(s): section to be repeated for (i) each type of

instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary shares of 5 pence each. 

b)

Identification code

ISIN: GB0004170089

c)

Nature of the transaction

Grant of nil-cost options over Ordinary Shares under the Company's Performance Share Plan

d)

Price(s) and

volume(s)

Price(s)

Volume(s)

Nil

395,402

e)

Aggregated information

- Volume

- Price

N/A

f)

Date of the transaction

18 March 2024

g)

Place of the transaction

Outside a trading venue

 

 

1.

Details of PDMR / person closely associated with them ("PCA")

a)

Name

Adam Phillips

2.

Reason for the notification

a)

Position / status

Chief Financial Officer

b)

Initial notification / amendment

Initial notification

3.

Details of the issuer

a)

Name

Headlam Group plc

b)

LEI

213800I4AZZUJEYX9O90

4.

Details of the transaction(s): section to be repeated for (i) each type of

instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary shares of 5 pence each. 

b)

Identification code

ISIN: GB0004170089

c)

Nature of the transaction

Grant of nil-cost options over Ordinary Shares under the Company's Performance Share Plan

d)

Price(s) and

volume(s)

Price(s)

Volume(s)

Nil

265,233

e)

Aggregated information

- Volume

- Price

N/A

f)

Date of the transaction

18 March 2024

g)

Place of the transaction

Outside a trading venue

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHQVLFFZXLEBBZ
Date   Source Headline
21st May 20217:01 amRNSPublication of ESG Strategy Report
21st May 20217:00 amRNSAGM Trading Update
14th May 20217:00 amRNSAppointment of Non-Executive Director
12th May 20211:01 pmRNSOption Exercise and Transfer of Treasury Shares
30th Apr 20217:00 amRNSDisposal of Swiss Business
9th Apr 20212:28 pmRNSPerformance Share Plan awards
31st Mar 20214:50 pmRNSExercise of share options and TVR
24th Mar 202111:59 amRNSAnnual Report and Accounts and Notice of AGM
10th Mar 202111:56 amRNSDividend Payment Date
9th Mar 20217:00 amRNSFinal Results
1st Mar 20213:58 pmRNSTotal Voting Rights
2nd Feb 20213:36 pmRNSOption Exercise and Transfer of Treasury Shares.
1st Feb 20219:48 amRNSTotal Voting Rights
21st Jan 202112:19 pmRNSHolding(s) in Company
21st Jan 20217:00 amRNSTrading Update
6th Jan 202110:47 amRNSOption Exercise and Transfer of Treasury Shares
6th Jan 20217:00 amRNSCOVID-19 Operational Update
31st Dec 202011:31 amRNSTotal Voting Rights
22nd Dec 202011:31 amRNSOption Exercise and Transfer of Treasury Shares
16th Dec 20207:00 amRNSDirectorate Change
8th Dec 20209:41 amRNSOption Exercise and Transfer of Treasury Shares
4th Dec 202011:00 amRNSAdditional Listing and Total Voting Rights
1st Dec 20208:17 amRNSHolding(s) in Company
24th Nov 20207:00 amRNSNotice of cyber security incident
19th Nov 20207:00 amRNSTrading Update
5th Nov 20207:00 amRNSCOVID-19 Operational Update
8th Oct 20201:36 pmRNSDirector/PDMR Shareholding
5th Oct 20202:29 pmRNSEmployee SAYE scheme & Director/PDMR shareholding
14th Sep 20203:43 pmRNSGrant of Awards under Long-Term Incentive Plans
10th Sep 20208:30 amRNSHolding(s) in Company
3rd Sep 20207:00 amRNSInterim Results
13th Aug 20208:44 amRNSHolding(s) in Company
10th Aug 202012:05 pmRNSHolding(s) in Company
7th Aug 20204:35 pmRNSPrice Monitoring Extension
7th Aug 20207:00 amRNSHolding(s) in Company
28th Jul 202011:13 amRNSDirector/PDMR Shareholding
28th Jul 20209:18 amRNSHolding(s) in Company
27th Jul 20207:00 amRNSTrading Update and New Distribution Centre
23rd Jun 20208:50 amRNSHolding(s) in Company
22nd May 202011:21 amRNSResult of AGM
22nd May 20207:00 amRNSAGM Trading Update
14th May 202012:08 pmRNSSecond Price Monitoring Extn
14th May 202012:02 pmRNSPrice Monitoring Extension
29th Apr 202010:34 amRNSDisclosure of Rights Attached to Equity Shares
28th Apr 202012:08 pmRNSSecond Price Monitoring Extn
28th Apr 202012:02 pmRNSPrice Monitoring Extension
27th Apr 20202:35 pmRNSDirector Declaration
27th Apr 202012:08 pmRNSSecond Price Monitoring Extn
27th Apr 202012:02 pmRNSPrice Monitoring Extension
23rd Apr 20202:20 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.